Vanguard European Stock Index Fund EUR AccRegister to Unlock Ratings |
Performance History | 31/07/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 2.3 | 17.7 | -4.1 | 13.4 | 7.5 | |
+/-Cat | -2.0 | 2.4 | 4.2 | 1.9 | 1.6 | |
+/-B’mrk | -0.2 | 0.1 | 0.5 | 0.3 | 0.0 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
NAV 14/08/2024 | EUR 31.45 | |
Day Change | 0.97% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
ISIN | IE0007987708 | |
Fund Size (Mil) 14/08/2024 | USD 4373.10 | |
Share Class Size (Mil) 14/08/2024 | EUR 2079.19 | |
Max Initial Charge | - | |
Ongoing Charge 15/02/2022 | 0.12% |
Investment Objective: Vanguard European Stock Index Fund EUR Acc |
The Fund seeks to provide long-term growth of capital by tracking the performance of the Index. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Not Disclosed 14/09/1998 | ||
Inception Date 08/06/2000 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR USD | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Vanguard European Stock Index Fund EUR Acc | 30/06/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 4.34 |
ASML Holding NV | Technology | 3.80 |
Nestle SA | Consumer Defensive | 2.51 |
AstraZeneca PLC | Healthcare | 2.23 |
Shell PLC | Energy | 2.11 |
Increase Decrease New since last portfolio | ||
Vanguard European Stock Index Fund EUR Acc |